Department of Psychology, Stanford University, Stanford, CA, USA.
Health Psychology Section, Department of Psychology, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
Ann Behav Med. 2023 Oct 16;57(11):901-909. doi: 10.1093/abm/kaad020.
Side-effect concerns are a major barrier to vaccination against COVID-19 and other diseases. Identifying cost- and time-efficient interventions to improve vaccine experience and reduce vaccine hesitancy-without withholding information about side effects-is critical.
Determine whether a brief symptom as positive signals mindset intervention can improve vaccine experience and reduce vaccine hesitancy after the COVID-19 vaccination.
English-speaking adults (18+) were recruited during the 15-min wait period after receiving their second dose of the Pfizer COVID-19 vaccination and were randomly allocated to the symptom as positive signals mindset condition or the treatment as usual control. Participants in the mindset intervention viewed a 3:43-min video explaining how the body responds to vaccinations and how common side effects such as fatigue, sore arm, and fever are signs that the vaccination is helping the body boost immunity. The control group received standard vaccination center information.
Mindset participants (N = 260) versus controls (N = 268) reported significantly less worry about symptoms at day 3 [t(506)=2.60, p=.01, d=0.23], fewer symptoms immediately following the vaccine [t(484)=2.75, p=.006, d=0.24], and increased intentions to vaccinate against viruses like COVID-19 in the future [t(514)=-2.57, p=.01, d=0.22]. No significant differences for side-effect frequency at day 3, coping, or impact.
This study supports the use of a brief video aimed at reframing symptoms as positive signals to reduce worry and increase future vaccine intentions.
Australian New Zealand Clinical Trials Registry: ACTRN12621000722897p.
对副作用的担忧是接种 COVID-19 和其他疾病疫苗的主要障碍。确定具有成本效益和时间效益的干预措施,以改善疫苗体验并降低疫苗犹豫,同时不隐瞒有关副作用的信息,这是至关重要的。
确定简短的症状积极信号思维干预是否可以改善 COVID-19 疫苗接种后的疫苗体验并降低疫苗犹豫。
在接种第二剂辉瑞 COVID-19 疫苗后的 15 分钟等待期内,招募了讲英语的成年人(18 岁以上),并将他们随机分配到症状积极信号思维条件或常规治疗对照组。思维干预组观看了一个 3 分 43 秒的视频,该视频解释了身体对疫苗接种的反应方式,以及疲劳、手臂酸痛和发烧等常见副作用是疫苗帮助身体增强免疫力的信号。对照组接受了标准的疫苗接种中心信息。
与对照组(N=268)相比,思维组(N=260)在第 3 天报告的症状担忧明显减少[(506)=2.60,p=.01,d=0.23],接种后立即出现的症状较少[(484)=2.75,p=.006,d=0.24],并且未来接种 COVID-19 等病毒的意愿增加[(514)=-2.57,p=.01,d=0.22]。在第 3 天的副作用频率、应对或影响方面没有显著差异。
这项研究支持使用旨在将症状重新定义为积极信号的简短视频来减少担忧并增加未来的疫苗接种意愿。
澳大利亚新西兰临床试验注册处:ACTRN12621000722897p。